Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

SANOFI INDIA LTD.

NSE : SANOFIBSE : 500674ISIN CODE : INE058A01010Industry : Pharmaceuticals & DrugsHouse : Sanofi India - MNC

BSE4120.0052.1 (+1.28 %)

PREV CLOSE ( ) 4067.90

OPEN PRICE ( ) 4100.00

BID PRICE (QTY) 4113.85 (8)

OFFER PRICE (QTY) 4120.45 (8)

VOLUME 341

TODAY'S LOW / HIGH ( )4092.05 4130.00

52 WK LOW / HIGH ( )4057.25 6717.5

NSE4115.8046.8 (+1.15 %)

PREV CLOSE( ) 4069.00

OPEN PRICE ( ) 4100.00

BID PRICE (QTY) 4115.70 (6)

OFFER PRICE (QTY) 4119.10 (8)

VOLUME 6230

TODAY'S LOW / HIGH( ) 4086.90 4131.90

52 WK LOW / HIGH ( )4058 6717

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 02-05 1956

Management Info

Aditya Narayan - Chairman - Managing Director

Registered Office

Address Sanofi House, C T S No. 117- B,L & T Business Park,Saki Vihar Road, Powai,
Mumbai,
Maharashtra-400072

Phone 022-2803 2000

Email igrc.sil@sanofi.com

Website www.sanofiindialtd.com

Registrars Details

MUFG Intime India Pvt Ltd.

C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai

Listing : BSE, NSE

NEWS

22Dec Sanofi India informs about disclosure
In compliance with Regulation 30 of the SEBI (LODR) Regulations, Sanofi..

18Dec Sanofi India informs about voting resu
Further to intimation dated 17th November 2025, Sanofi India has informe..

29Oct Sanofi India informs about presentation
With reference to intimation dated 23rd October 2025, informing about th..

27Oct Appointment of Director
Iinter-alia considered and approved the following matter(s): 1. Upon..

18Jul Sanofi India informs about board meeti
Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosur..

Financials

Rs. in Millions

	QTR Sep 25	ANNUAL 24
Net Profit	760	4135
Gross Profit	1023	4314
Operating Profit	1391	5073
Net Sales	4754	20132

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Fredun Pharma (BSE) 1748.00 (7.19%)	M.Cap ( in Cr)821.57
Alkem Laboratories (BSE) 5637.55 (1.37%)	M.Cap ( in Cr)67433.46
Abbott India (BSE) 28110.00 (0.25%)	M.Cap ( in Cr)59751.97
Astrazeneca Pharma I (BSE) 9130.95 (0.76%)	M.Cap ( in Cr)22794.75
Ajanta Pharma (BSE) 2690.05 (2.58%)	M.Cap ( in Cr)33532.72

Shareholding Pattern

	PROMOTERS	60.4%
	FI/BANKS/INSURANCE	11.86%
	NON-INSTITUTION	11.75%
	MUTUAL FUNDS/UTI	10.42%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
Baroda BNP Paribas ...	1.98
Nippon India Pharma...	1.71
PGIM India Healthca...	1.65
Aditya Birla SL Pha...	1.46
Baroda BNP Paribas ...	1.21
Baroda BNP Paribas ...	1.18
SBI Midcap Fund-Reg(G)	1.15

Risk Disclosures on Derivatives

Smart Quotes

SANOFI INDIA LTD.